Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sulzer Orthopedics invests $6.75mm in ReGen Biologics

Executive Summary

The Sulzer Group's Sulzer Orthopedics and Intermedics Orthopedics have completed a $6.75mm equity investment in ReGen Biologics (resorbable collagen templates), purchasing 931,035 shares or about a 14% stake in ReGen.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register